CN1272341C - 肽的纯化 - Google Patents

肽的纯化 Download PDF

Info

Publication number
CN1272341C
CN1272341C CNB028283481A CN02828348A CN1272341C CN 1272341 C CN1272341 C CN 1272341C CN B028283481 A CNB028283481 A CN B028283481A CN 02828348 A CN02828348 A CN 02828348A CN 1272341 C CN1272341 C CN 1272341C
Authority
CN
China
Prior art keywords
solvent mixture
decapeptide
nonapeptide
precipitation
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028283481A
Other languages
English (en)
Chinese (zh)
Other versions
CN1625561A (zh
Inventor
J·H·拉斯姆森
P·H·拉斯姆森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CARLBIOTECH Ltd AS
Original Assignee
CARLBIOTECH Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CARLBIOTECH Ltd AS filed Critical CARLBIOTECH Ltd AS
Publication of CN1625561A publication Critical patent/CN1625561A/zh
Application granted granted Critical
Publication of CN1272341C publication Critical patent/CN1272341C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNB028283481A 2001-12-29 2002-12-23 肽的纯化 Expired - Fee Related CN1272341C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE01044627 2001-12-29
SE0104462A SE0104462D0 (sv) 2001-12-29 2001-12-29 Peptide purifcation (Peptidrening)

Publications (2)

Publication Number Publication Date
CN1625561A CN1625561A (zh) 2005-06-08
CN1272341C true CN1272341C (zh) 2006-08-30

Family

ID=20286556

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028283481A Expired - Fee Related CN1272341C (zh) 2001-12-29 2002-12-23 肽的纯化

Country Status (18)

Country Link
US (1) US7057014B2 (enExample)
EP (1) EP1468009B1 (enExample)
JP (1) JP4378173B2 (enExample)
KR (1) KR100880828B1 (enExample)
CN (1) CN1272341C (enExample)
AT (1) ATE449784T1 (enExample)
AU (1) AU2002347550B2 (enExample)
CA (1) CA2471717C (enExample)
DE (1) DE60234535D1 (enExample)
DK (1) DK1468009T3 (enExample)
ES (1) ES2350880T3 (enExample)
IL (2) IL162789A0 (enExample)
NO (1) NO329024B1 (enExample)
NZ (1) NZ534151A (enExample)
RU (1) RU2303040C2 (enExample)
SE (1) SE0104462D0 (enExample)
WO (1) WO2003055900A1 (enExample)
ZA (1) ZA200405135B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1359722A1 (en) * 2002-03-27 2003-11-05 BRITISH TELECOMMUNICATIONS public limited company Data streaming system and method
KR101346886B1 (ko) 2005-01-21 2014-01-02 아스텍스 테라퓨틱스 리미티드 제약 화합물
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
US9051349B2 (en) 2007-11-21 2015-06-09 Alba Therapeutics Corporation Larazotide acetate compositions
EP2062909A1 (en) * 2007-11-21 2009-05-27 SOLVAY (Société Anonyme) Peptide production and purification process
US20120149868A1 (en) * 2008-05-15 2012-06-14 Novo Nordisk A/S Purification of peptides prepared by solid phase synthesis
ES2439998T3 (es) * 2009-04-10 2014-01-27 Corden Pharma Colorado, Inc. Procedimiento para aislar linaclotida
ES2819573T3 (es) 2012-12-13 2021-04-16 Immunomedics Inc Método para producir inmunoconjugados de anticuerpo-SN-38 con un enlazador CL2A
PL2900277T3 (pl) 2012-12-13 2022-05-16 Immunomedics, Inc. Dawkowanie immunokoniugatów przeciwciał i sn-38 dla poprawy skuteczności i zmniejszenia toksyczności
US9931417B2 (en) 2012-12-13 2018-04-03 Immunomedics, Inc. Antibody-SN-38 immunoconjugates with a CL2A linker
EP3024460B1 (en) * 2013-07-23 2020-07-22 Immunomedics, Inc. Method for producing antibody-sn-38 immunoconjugates with a cl2a linker
AU2017257254B2 (en) 2016-04-27 2022-02-24 Immunomedics, Inc. Efficacy of anti-Trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refractory to checkpoint inhibitors
RU2758234C2 (ru) 2017-03-27 2021-10-26 Иммьюномедикс, Инк. ЛЕЧЕНИЕ ТРИЖДЫ НЕГАТИВНОГО РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ, ХАРАКТЕРИЗУЮЩЕГОСЯ ЭКСПРЕССИЕЙ Trop-2, С ПОМОЩЬЮ САЦИТУЗУМАБА ГОВИТЕКАНА И ИНГИБИТОРА Rad51
WO2018187074A1 (en) 2017-04-03 2018-10-11 Immunomedics, Inc. Subcutaneous administration of antibody-drug conjugates for cancer therapy
CN113952944B (zh) * 2021-12-23 2022-03-29 浙江湃肽生物有限公司深圳分公司 一种纯化九肽-1的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317697D0 (en) * 1983-06-29 1983-08-03 Shell Int Research Dissolution of peptides in non-aqueous and mixed non-aqueous/aqueous solvents
DE4001238A1 (de) * 1990-01-18 1991-07-25 Basf Ag Verfahren zur anreicherung bzw. reinigung von biomolekuelen
DE19544212A1 (de) * 1995-11-28 1997-06-05 Asta Medica Ag Neue LH-RH-Antagonisten mit verbesserter Wirkung
DE19813849A1 (de) * 1998-03-27 1999-09-30 Degussa Verfahren zur einstufigen Umsalzung und Aufreinigung von Oligopeptiden
EP0998940A1 (en) 1998-09-30 2000-05-10 Laboratoire Theramex Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung

Also Published As

Publication number Publication date
US7057014B2 (en) 2006-06-06
EP1468009A1 (en) 2004-10-20
JP2005515217A (ja) 2005-05-26
AU2002347550A1 (en) 2003-07-15
ES2350880T3 (es) 2011-01-27
HK1076112A1 (en) 2006-01-06
KR20040090966A (ko) 2004-10-27
KR100880828B1 (ko) 2009-01-30
CA2471717C (en) 2013-06-18
NZ534151A (en) 2007-05-31
WO2003055900A1 (en) 2003-07-10
RU2004119965A (ru) 2006-01-10
ATE449784T1 (de) 2009-12-15
IL162789A0 (en) 2005-11-20
CN1625561A (zh) 2005-06-08
DE60234535D1 (de) 2010-01-07
NO20043046L (no) 2004-08-30
SE0104462D0 (sv) 2001-12-29
EP1468009B1 (en) 2009-11-25
US20060014694A1 (en) 2006-01-19
ZA200405135B (en) 2005-08-31
AU2002347550B2 (en) 2008-01-03
DK1468009T3 (da) 2010-04-06
IL162789A (en) 2010-04-29
CA2471717A1 (en) 2003-07-10
RU2303040C2 (ru) 2007-07-20
JP4378173B2 (ja) 2009-12-02
NO329024B1 (no) 2010-08-02

Similar Documents

Publication Publication Date Title
CN1272341C (zh) 肽的纯化
CN1127497C (zh) 苯并(b)硫杂环庚三烯－1,1－二氧化物类衍生物、其制备方法、含有这些化合物的药物组合物及其应用
EP1206485A2 (de) Neue effektoren der dipeptidyl peptidase iv zur topischen anwendung
CN103180336B (zh) 用于分离环六肽的方法
CN102947327B (zh) 卡泊芬净中间体的纯化
CA2196450A1 (fr) Forme purifiee de streptogramines, sa preparation et les compositions pharmaceutiques qui la contiennent
JP2005515217A5 (enExample)
CN1291238A (zh) 获得高纯度HMG－CoA还原酶抑制剂的方法
CN1125952A (zh) 1-脱氨基-8-d-精氨酸抗利尿激素的制造方法
CN1033976C (zh) 用作钙通路阻滞剂的多肽的制备方法
EP3239165B1 (en) Composition containing nitrogen heterocyclic hexapeptide precursor and preparation method and application thereof
CN1717386A (zh) 提纯双醋瑞因的方法
CN1182139C (zh) 制造纯的药典级无定形头孢呋辛的1-乙酸乙基酯的方法
CN1202131C (zh) 一锅法液相合成胸腺五肽的工艺
CN1222528C (zh) 提纯克拉布兰酸盐的方法
HK1076112B (en) Peptide purification
CA2087379A1 (fr) Derives pseudopeptidiques a activite antagoniste de la bradykinine, leur procede de preparation et les compositions pharmaceutiques qui en contiennent
CN1522255A (zh) 结晶亚胺培南的分离方法
CN1198183A (zh) 烷氧基化脂肪纯化的方法
EP0432022B1 (fr) Milieu réactionnel et solubilisant de peptides et procédé de synthèse de peptides utilisant ce milieu
JPH07100715B2 (ja) シクロヘキサペプチジルヒドロキシプロピオニトリル化合物
HK1012859B (en) Peptide and method of obtaining it
FR2655348A1 (fr) Milieu reactionnel et solubilisant de peptides et procede de synthese de peptides utilisant ce milieu.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1076112

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060830

Termination date: 20161223

CF01 Termination of patent right due to non-payment of annual fee